Drugs Made In America Acquisition (DMIIR) Financials: Revenue & Earnings
DMIIR$0.05-0.02 -25.00%
$3.34M
Market Cap
—
P/E
—
Forward P/E
—
Score
Drugs Made In America Acquisition (DMIIR) Financials: Revenue & Earnings
DMIIR price $0.05 -0.02 -25.00%
- Ticker
- DMIIR
- Price
- $0.05
- Change
- -0.02 -25.00%
- Market cap ?
- $3.34M
- Beta ?
- 2.05
- Sector
- Financial Services
- Industry
- Financial - Conglomerates
Fair value
DMIIR fair value $2.86. Price $0.05. Price is 98% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| No data yet. | ||||
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| No data yet. | |||||
Institutional holders
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| No data yet. | ||||
Earnings and financials
Drugs Made In America Acquisition II Corp. (DMIIR) trades at $0.05, with a market cap of $3.34M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn